Stock Market
Sensex Crashes Over 600 Points as Nifty Slips Below 24,050: 3 Reasons Behind Today’s Market Meltdown…
Indian stock markets opened sharply lower on Wednesday as pharma shares came under pressure over US tariff concerns, crude oil prices surged above $92 a barrel and widespread selling hit banking, IT and other major sectors.
The Indian stock market started Wednesday’s trading session on a weak note, with benchmark indices facing heavy selling pressure right from the opening bell. The BSE Sensex plunged nearly 600 points in early trade, while the NSE Nifty 50 slipped below the crucial 24,050 level as investors turned cautious amid a mix of global and domestic concerns.
Around 9:35 am, the Sensex was trading at 76,866.60, down 603.51 points, or 0.78%. The Nifty 50, meanwhile, fell 160.75 points, or 0.66%, to 24,026.95.
The sell-off was not restricted to the headline indices. Mid-cap and small-cap stocks also came under pressure, with the Nifty Smallcap 100 declining 1.10%. The Nifty Midcap 100 and Nifty Midcap 50 were down 0.70% and 0.74%, respectively.
At the same time, the India VIX, often referred to as the market’s fear gauge, climbed 2.79%, signalling that investors were bracing for increased volatility.
So, what exactly triggered the sudden fall?
Here are three major reasons behind Wednesday’s market decline.
1. Pharma Stocks Tumble Over US Tariff Concerns
The biggest pressure point for the market came from the pharmaceutical sector.
Pharma shares witnessed aggressive selling after Donald Trump outlined a phased tariff plan targeting imported generic medicines. While drugmakers have reportedly been given a two-year window before the proposed duties take effect, investors quickly reacted to the potential impact on India’s pharmaceutical exporters.
The Nifty Pharma index dropped around 1.70%, making it the worst-performing major sector during early trading.
Several prominent pharmaceutical companies were caught in the sell-off. Gland Pharma fell 3.57%, while Piramal Pharma declined 3.28%. Alkem Laboratories dropped 2.97%, Lupin slipped 2.92% and Ajanta Pharma declined 2.88%.
Aurobindo Pharma was also down nearly 2.79%.
Read More- Sensex Soars 965 Points Despite Global Market Chaos: 4 Powerful Reasons Why D-Street Defied the Odds
The pressure spread beyond pharma companies, with the Nifty Healthcare index falling 1.50%. Stocks including Glenmark, Biocon and Laurus Labs also traded lower.
For investors, the concern is clear: any significant tariff imposed on Indian generic medicines could affect companies with substantial exposure to the US market. That uncertainty was enough to trigger a fresh wave of selling across the sector.
2. Brent Crude Crosses $92 as Middle East Tensions Escalate
The second major worry came from the energy market.
Brent crude oil climbed 1.16% to around $92.07 per barrel, reaching its highest level since June. Meanwhile, WTI crude gained 1.03% to approximately $85.21 a barrel.
The sharp rise in oil prices is a concern for India because the country is among the world’s largest crude oil importers.
Higher crude prices can increase India’s import bill and put additional pressure on inflation. They can also raise operating costs for businesses that depend heavily on fuel and petroleum-based raw materials.

Sectors such as aviation, paints, chemicals and FMCG are particularly sensitive to rising input costs. If crude remains elevated for an extended period, investors may begin worrying about corporate profit margins.
Dr. VK Vijayakumar, Chief Investment Strategist at Geojit Investments, highlighted geopolitics and crude oil as key near-term risks for the market.
According to Vijayakumar, the continuing US-Iran conflict and higher Brent crude prices could continue weighing on investor sentiment, even as positive developments emerge in other areas of the economy.
His comments underline the difficult balancing act facing investors: while some parts of the Indian economy are showing resilience, geopolitical uncertainty and expensive oil continue to create a major cloud over the market.
3. Selling Spreads Across Banks, IT and Other Sectors
The market decline was also fuelled by broad-based selling.
As many as 10 of the 16 major sectoral indices were trading in negative territory during early trade, suggesting that Wednesday’s weakness was much broader than a single-sector correction.
Banking stocks were among the major casualties.
The Nifty PSU Bank index fell 1.38%, while the Nifty Private Bank index declined 1.09%. The Nifty Financial Services index also slipped 0.97%.
Among major banking stocks, State Bank of India declined 1.46%. Axis Bank fell 1.34%, while ICICI Bank dropped 1.28%. HDFC Bank lost 0.99%, and Kotak Mahindra Bank was down 0.78%.
The IT sector was not spared either.
The Nifty IT index fell 0.73%, with Tech Mahindra declining 1.15%, Infosys slipping 0.91% and Tata Consultancy Services falling 0.39%.
Heavyweights such as Reliance Industries also traded lower, adding to the pressure on the benchmark indices.
Auto Stocks Offer a Rare Bright Spot
Amid the widespread market weakness, the automobile sector emerged as one of the few pockets of strength.
The Nifty Auto index gained around 0.37%, helped by encouraging updates from automobile companies related to the June quarter.
Titan Company was another notable gainer, rising around 0.64%.
The relative resilience of auto stocks offered investors a small positive signal in an otherwise difficult trading session.
Could This Market Correction Create a Buying Opportunity?
Despite the sharp fall, market strategist VK Vijayakumar believes the correction could eventually create opportunities for long-term investors.
He pointed towards valuations in some leading banking stocks, suggesting that the recent price decline may have opened up value in fundamentally strong companies.
The strategist also noted that foreign investors have not been consistently aggressive sellers and have even turned buyers during some trading sessions.
The Indian rupee could also find some support from strong FCNR deposit inflows, which have reportedly crossed the $20 billion mark.
For investors, however, the immediate focus is likely to remain on crude oil prices, geopolitical developments and the potential impact of US trade policies.
What Happens Next for the Sensex and Nifty?
Wednesday’s market fall highlights how quickly sentiment can turn when multiple concerns hit investors at the same time.
The combination of US tariff worries, rising crude oil prices and broad-based selling created a difficult start to the trading session. With the India VIX also moving higher, volatility could remain elevated in the near term.
At the same time, analysts believe that market corrections can create opportunities for investors with a long-term horizon, particularly in fundamentally strong companies that experience temporary pressure due to broader market sentiment.
For now, however, the message from Dalal Street is clear: investors are watching crude oil and geopolitics closely—and any fresh shock could decide where the market goes next…
